By Christy Santhosh (Reuters) -Pfizer CEO Albert Bourla said on Monday the drugmaker might move overseas manufacturing to its ...

B.Riley Financial analyst Madison Elsaadi reiterated a Buy rating on Eton Pharmaceuticals (ETON – Research Report) today and set a price target ...

H.C. Wainwright analyst Joseph Pantginis maintained a Buy rating on Lexicon Pharmaceuticals (LXRX – Research Report) today and set a price ...

We recently compiled a list of the Top 10 Stocks to Buy According to Lone Pine Capital. In this article, we are going to take ...

The global material informatics market size is projected to grow from USD 170.4 million in 2025 to USD 410.4 million in 2030, ...

Sun Pharmaceutical Industries Ltd. closed 19.13% below its 52-week high of 1,960.20 rupees, which the company reached on September 30th.

The first week of February saw more flu cases in Pennsylvania than any other week over the past five years with almost 29,000 infections, data from the state Department of Health show.

A clinical trial has found that the medication omalizumab, marketed as Xolair, treated multi-food allergy more effectively ...

We believe there is minimal cause for concern with LLY stock, which makes it attractive but highly sensitive to adverse ...

In response to the growing demand for high-quality health supplements in the Philippines, Sole Pharma, as one of the leading ...

The National Agency for Food and Drug Administration and Control (NAFDAC) has blacklisted an Indian pharmaceutical company, ...

The National Agency for Food and Drug Administration and Control (NAFDAC) has blacklisted Aveo Pharmaceuticals Pt Limited, an ...